MX2020011399A - Administración dirigida de progestinas y estrógenos a través de dispositivos de anillo vaginal para control de la fertilidad y productos hrt. - Google Patents

Administración dirigida de progestinas y estrógenos a través de dispositivos de anillo vaginal para control de la fertilidad y productos hrt.

Info

Publication number
MX2020011399A
MX2020011399A MX2020011399A MX2020011399A MX2020011399A MX 2020011399 A MX2020011399 A MX 2020011399A MX 2020011399 A MX2020011399 A MX 2020011399A MX 2020011399 A MX2020011399 A MX 2020011399A MX 2020011399 A MX2020011399 A MX 2020011399A
Authority
MX
Mexico
Prior art keywords
progestins
estrogens
targeted delivery
vaginal ring
fertility control
Prior art date
Application number
MX2020011399A
Other languages
English (en)
Inventor
Klaus Nickisch
Karin Eggenreich
Walter Leger
Ze''ev SHAKED
Simone Eder
Andreas Witschnigg
Original Assignee
Evestra Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evestra Inc filed Critical Evestra Inc
Publication of MX2020011399A publication Critical patent/MX2020011399A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A61K9/025—Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen diversos dispositivos de administración de fármacos intravaginales para la administración de estrógenos y progestinas. La velocidad de liberación de estrógenos y progestinas se puede controlar mediante la variación del material de la matriz o mediante la aplicación de un recubrimiento fino. Los dispositivos de administración de fármacos intravaginales pueden estar compuestos por uno o más compartimentos individuales. Al controlar diversos parámetros físicos y químicos, se pueden lograr velocidades de liberación distintas de cero del estrógeno o de las progestinas.
MX2020011399A 2018-04-27 2019-04-26 Administración dirigida de progestinas y estrógenos a través de dispositivos de anillo vaginal para control de la fertilidad y productos hrt. MX2020011399A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862663584P 2018-04-27 2018-04-27
PCT/US2019/029289 WO2019210134A1 (en) 2018-04-27 2019-04-26 Targeted delivery of progestins and estrogens via vaginal ring devices for fertility control and hrt products

Publications (1)

Publication Number Publication Date
MX2020011399A true MX2020011399A (es) 2020-11-24

Family

ID=68291927

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020011321A MX2020011321A (es) 2018-04-27 2019-04-25 Profármacos de estrógeno y métodos de administración de profármacos de estrógeno.
MX2020011399A MX2020011399A (es) 2018-04-27 2019-04-26 Administración dirigida de progestinas y estrógenos a través de dispositivos de anillo vaginal para control de la fertilidad y productos hrt.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2020011321A MX2020011321A (es) 2018-04-27 2019-04-25 Profármacos de estrógeno y métodos de administración de profármacos de estrógeno.

Country Status (8)

Country Link
US (3) US20190328656A1 (es)
EP (2) EP3784247A1 (es)
AU (2) AU2019261454A1 (es)
BR (2) BR112020021994A2 (es)
CA (2) CA3098551A1 (es)
CL (2) CL2020002776A1 (es)
MX (2) MX2020011321A (es)
WO (2) WO2019210066A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019115343A1 (de) * 2019-06-06 2020-12-10 EVESTRA GmbH Vaginalring für die hormonelle Kontrazeption
WO2023200974A1 (en) * 2022-04-14 2023-10-19 Yale University Nanoparticles and nanoparticle-releasing vaginal rings

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE461681T1 (de) * 2003-04-29 2010-04-15 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
WO2010054296A2 (en) * 2008-11-07 2010-05-14 Combinent Biomedical Systems, Inc. Devices and methods for treating and/or preventing diseases
UY32492A (es) * 2009-03-17 2010-10-29 Organon Nv Dispositivo de suministro de droga zootécnica.
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device

Also Published As

Publication number Publication date
US20190328656A1 (en) 2019-10-31
EP3784180A1 (en) 2021-03-03
CA3098551A1 (en) 2019-10-31
BR112020021995A2 (pt) 2021-01-26
CL2020002776A1 (es) 2021-02-05
WO2019210066A1 (en) 2019-10-31
US20190328657A1 (en) 2019-10-31
US20190328658A1 (en) 2019-10-31
MX2020011321A (es) 2021-02-09
CA3098555A1 (en) 2019-10-31
AU2019261454A1 (en) 2020-12-03
AU2019257752A1 (en) 2020-12-03
WO2019210134A1 (en) 2019-10-31
EP3784247A1 (en) 2021-03-03
CL2020002778A1 (es) 2021-02-05
BR112020021994A2 (pt) 2021-01-26

Similar Documents

Publication Publication Date Title
MX2020011399A (es) Administración dirigida de progestinas y estrógenos a través de dispositivos de anillo vaginal para control de la fertilidad y productos hrt.
PH12016501298B1 (en) Aerosol-forming substrate and aerosol-delivery system
EP3782737A4 (en) SLOT DIE WASHER ADJUSTMENT DEVICE THAT ADJUSTS THE DISTANCE BETWEEN THE UPPER DISCHARGE PORT AND LOWER DISCHARGE OPENING OF A SLOT DIE WASHER, AND MATERIAL COATING SYSTEM ELECTRODE ACTIVE INCLUDING IT
WO2020081849A3 (en) Cartridge for a vaporizer device
PH12016502470A1 (en) Treatment for plant seeds
WO2017035381A8 (en) Delivery device and methods of use for transapical delivery of replacement mitral valve
MX2018015782A (es) Particula de suministro de polisacarido.
EP3818869A4 (en) AEROSOL GENERATION DEVICE AND METHOD AND DEVICE FOR CONTROLLING AN AEROSOL GENERATION DEVICE
AU2014375677A1 (en) Drug dosing device and method for dosage metering and control
MXPA05012835A (es) Dispositivos y sistemas para despachar materiales volatiles.
MX2022001477A (es) Configuracion de enlace lateral.
TN2012000468A1 (en) Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis
MX2018004534A (es) Metodo para suministrar una lamina continua de sustrato formador de aerosol desde una bobina y un articulo generador de aerosol.
MX2022007990A (es) Composiciones y metodos para usar un insecticida con bacillus sp. d747.
MX2019001370A (es) Sistema para preparar una bebida.
WO2015160741A3 (en) An apparatus for producing pouches
SG11202111675TA (en) Perforated chamber ostomy wafers,devices including the same, and methods of applying
WO2019013473A3 (ko) 금속 산화물이 코팅된 촉매 성형체와 그의 제조방법 및 이를 이용한 1,3-부타디엔 제조방법
MX2019001539A (es) Objetivo de pulverizacion catodica de calcogenuros y metodo para fabricarlo.
MX2022006477A (es) Un articulo para su uso en un sistema de suministro de aerosol no combustible.
MX2020001653A (es) Aparato, sistema y proceso para regular un mecanismo de control de un pozo.
ZA202204137B (en) Process for preparing (15αlpha,16αlpha,17βeta)-estra-1,3,5(10)-triene-3,15,16,17-tetrol (estetrol) and intermediates of said process
WO2020176902A8 (en) Cartridge for a vaporizer device
EP3896815A4 (en) HYDROGEN SYSTEM CONTROL DEVICE AND METHOD
ZA202206276B (en) Dispenser and method of use thereof